Stocks and InvestingStocks and Investing
Thu, July 22, 2021
Wed, July 21, 2021
Tue, July 20, 2021
Mon, July 19, 2021
Fri, July 16, 2021

Matthew Harrison Maintained (ADCT) at Buy with Decreased Target to $51 on, Jul 16th, 2021


Published on 2024-10-27 17:14:11 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "ADC Therapeutics SA" (ADCT) at Buy with Decreased Target from $53 to $51 on, Jul 16th, 2021.

Matthew has made no other calls on ADCT in the last 4 months.



There are 2 other peers that have a rating on ADCT. Out of the 2 peers that are also analyzing ADCT, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Brian Cheng of "Cantor Fitzgerald" Initiated at Buy and Held Target at $46 on, Tuesday, June 15th, 2021
  • Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Friday, May 14th, 2021